ArticleFrontiers in pediatrics2021

Tocilizumab in Systemic Juvenile Idiopathic Arthritis: Response Differs by Disease Duration at Medication Initiation and by Phenotype of Disease.

Xin Yan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.